Welcome to RheumMadness – the place for everyone who is crazy about rheumatology to connect, collaborate, compete, and learn together. RheumMadness is a project funded by a Clinician Scholar Educator Award from the Rheumatology Research Foundation and inspired by a similar project in nephrology called NephMadness.
Our theme for the 2023 tournament is RheumMadness: The All Star Season. This season, we will focus on the foundational science that has driven our field to where it is today. Each of the 22 teams in the tournament will represent one “all star” article competing to be named the most important and transformational article ever written in the field of rheumatology.
How to Play RheumMadness (it’s easy and FREE)
- Read “scouting reports” to learn about the teams in the tournament.
- Submit your picks before Wednesday, March 22 at 11:59pm ET.
- Enjoy! Tournament results will be released in 5 rounds from March 23 – April 3, 2023.
The RheumMadness OnePager
Need a quick review of the teams as you make your picks? We collaborated with Dr. Mithu Maheswaranathan (@MithuRheum), creator of @RheumOnePagers to create an infographic reviewing the entire bracket in one page. Check it out below.
How are matches determined?
The winner of each match-up is decided by a 7-member “Blue Ribbon Panel” of rheumatologists. For the 2023 tournament, the panel will vote based on which topic they think is the most important and transformational article ever written in the field of rheumatology. The more your picks match those of the panel, the more points you get! For more details about how RheumMadness works, check out our RheumMadness 101 page, which includes a short explainer video and details about our RheumMadness leadership team.
The 2023 Blue Ribbon Panel
We are thankful to have an amazing panel with diverse interests, areas of expertise, and practice settings.
- Angus B. Worthing, MD, FACP, FACR: Rheumatologist at Arthritis and Rheumatism Associates in Washington, D.C. Follow him at @AngusWorthing
- Anne R. Bass, MD: Rheumatologist at Hospital for Special Surgery and Professor of Clinical Medicine at Weill Cornell Medicine in New York, New York.
- Julie J. Paik, MD, MHS: Associate Professor at Johns Hopkins Hospital in Baltimore, Maryland. Follow her at @JuliePaikMD
- Marie Kuchynski, MD: Senior attending physician, rheumatologist at University Hospitals Cleveland Medical Center; Brunswick Ohio. Follow her at @DoctorKuch
- Peter C. Grayson, MD, MSc: Rheumatologist and Tenure Track Investigator at the National Institute of Arthritis and Musculoskeletal and Skin Diseases in Bethesda, Maryland. Follow him at @petercgrayson
- Sebastian E. Sattui, MD, MS: Assistant Professor at University of Pittsburgh Medical Center in Pittsburgh, Pennsylvania. Follow him at @SattuiSEMD
- Daniel E. Gonzalez, MD: Second-year rheumatology fellow at University of Texas Medical Branch in Galveston, Texas.
What do I get if I win?
Participants with the most correct predictions will “win” RheumMadness. Prizes will be given to participants with the top scores in the following categories: (1) Attending / APP, (2) Fellow, and (3) Resident / Medical Student. The prize is a custom RheumMadness coffee mug and a lifetime of bragging rights. But really, everyone wins in RheumMadness because you get to connect, collaborate, compete, and learn together.
Ready to start learning about the teams in the tournament? This year, the scouting reports were authored by 123 collaborators from 19 fellowship programs and 2 private practice groups, including 76 fellows, 40 faculty, 4 residents, and 3 medical students. What an amazing collaboration!
- Etanercept for RA, by the Ohio State Fellowship Program
- Etanercept + MTX, by the University of Chicago Fellowship Program
- Infliximab for RA, but the University of California San Diego Fellowship Program
- TEAR Triple Rx, by the UT Southwestern Fellowship Program
- BeSt Trial, by the Medical University of South Carolina Fellowship Program
- TICORA Trial, by the Arthritis & Rheumatism Associates Practice, Washington DC
- Clonal Selection, by the Vanderbilt University Medical Center Fellowship Program
- MSU & NLRP3, by the Geisinger Medical Center Fellowship Program
- Abs before SLE, by the Massachusetts General Hospital Fellowship Program
- CCP & Enolase, by the University of South Florida Fellowship Program
- Pathogenic ANCA, by the University of North Carolina Fellowship Program
- CYC for PAN, by the Allegheny Health Network Fellowship Program
- CYC in Scleroderma, by the Louisiana State University Shreveport Fellowship
- ULT During Flare, by the Medical College of Wisconsin Fellowship Program
- RAVE Trial, by the Wake Forest Fellowship Program
- HCQ Withdrawal, by Bryn Mawr Medical Specialists Association Practice
- ALMS Trial, by the University of Alabama and Birmingham Fellowship Program
- LUMINA, by the Northwestern University Fellowship Program
- HAQ, by the RheumMadness Leadership Team
- Cortisone, by the University of Colorado Fellowship Program
- Origin of RA, by the Duke University Fellowship Program
- Origin of sJIA, by the Montefiore Pediatric Fellowship Program
The RheumMadness team is excited to announce a collaboration with theMednet.org for our 2023 tournament. theMednet is a physician only site providing a space for physicians to tackle difficult clinical questions and see how colleagues are practicing. theMednet will be featuring select Q&A relevant to articles in our 2023 tournament and will provide a space for further discussion and polling around clinical application. Register here for a free account with full access to the theMednet site and find RheumMadness content. Get FREE CME and MOC credit for reviewing this material.
- Listen to the RheumMadness podcast. In this podcast series, we interview fellows who wrote the scouting reports. You can find the podcast on all major podcasting apps.
- Join the conversation on Twitter (#RheumMadness).
